Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease
详细信息 查看全文
- 作者：Lisanne C. de Vosa ; Joop D. Lefrandta ; Robin P.F. Dullaartb ; Clark J. Zeebregtsc ; Andries J. Smita ; a.j.smit@umcg.nl" class="auth_mail" title="E-mail the corresponding author
- 关键词：Advanced glycation end products ; Peripheral artery disease ; Biomarker ; Atherosclerosis
- 刊名：Atherosclerosis
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：254
- 期：Complete
- 页码：291-299
- 全文大小：1181 K
文摘
- •
An emerging biomarker is advanced glycation end products (AGEs).
- •
AGEs are strongly associated with peripheral artery disease (PAD).
- •
Skin autofluorescence (SAF) is a noninvasive method to assess skin AGEs.
- •
SAF identifies PAD patients at highest risk for local and cardiovascular end points.